Antibiotics and Innovation


Research & Analysis

View All
  • Tracking the Pipeline of Antibiotics in Development

    Drug-resistant bacteria, or superbugs, present a serious and worsening threat to human health. According to a Centers for Disease Control and Prevention report, 2 million Americans acquire serious infections caused by antibiotic-resistant bacteria each year, and 23,000 of them die.1  Doctors routinely encounter patients with infections that do not respond to available treatment, and when new... Read More

  • National Action on Antibiotic Resistance

    On Sept. 18, the Obama administration took unprecedented action to combat antibiotic-resistant bacteria, a significant public health problem that claims 23,000 lives and causes 2 million infections in the U.S. each year.  The administration released a national strategy and executive order, which were accompanied by a report from the President’s Council of Advisors for Science and... Read More

  • Allan Coukell on Ways to Spur Antibiotic Development

    On September 19, Allan Coukell, senior director of drugs and medical devices testified, delivered testimony in front of the House Committee on Energy and Commerce Health Subcommittee at a hearing entitled “Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development." Read More

Media Contact

Linda Paris

Officer, Communications

202.540.6354